{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001252","form_type":"8-K","ticker":"GTHP","cik":"0000924515","company_name":"GUIDED THERAPEUTICS INC","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.066966+00:00","generated_at":"2026-05-15T17:24:38.173080+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Guided Therapeutics completes warrant exchange; issues 4.825M shares for $980K cash","bullets":["Holders of 4.825M eligible warrants (22.7% of total) tendered; exchanged for restricted common stock at reduced exercise prices.","Exercise price for $0.65 warrants reduced to $0.25; for $0.50 warrants reduced to $0.20, generating $980K total cash proceeds.","After exchange, company has 91.5M shares outstanding; 16.4M eligible warrants remain, most expiring Sep–Oct 2026.","Remaining unexercised warrants held by participating holders have expiration extended by one year.","Shares issued under Section 3(a)(9) exemption; no commissions paid for solicitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001252","json":"https://secwatch.observer/filing/0001477932-26-001252.json","markdown":"https://secwatch.observer/filing/0001477932-26-001252.md","text":"https://secwatch.observer/filing/0001477932-26-001252.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/924515/000147793226001252/0001477932-26-001252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/924515/000147793226001252/gthp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:24:38.173080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7dcf816224ecf5cf8f761b16feac78db0203bfbc","claim":"GUIDED THERAPEUTICS INC issued 4,825,000 shares of common stock to holders of Eligible Warrants.","evidence_excerpt":"on March 2, 2026, the Company issued an aggregate of 4,825,000 shares of Common Stock to holders of Eligible Warrants.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226001252/0001477932-26-001252-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"4,825,000 shares"},{"label":"Purchaser","value":"holders of Eligible Warrants"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}